2-{2-[5-(3,4-dimethoxyphenyl)-3-(4-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide
Chemical Structure Depiction of
2-{2-[5-(3,4-dimethoxyphenyl)-3-(4-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide
2-{2-[5-(3,4-dimethoxyphenyl)-3-(4-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide
Compound characteristics
Compound ID: | C202-1646 |
Compound Name: | 2-{2-[5-(3,4-dimethoxyphenyl)-3-(4-methylphenyl)-4,5-dihydro-1H-pyrazol-1-yl]-4-oxo-4,5-dihydro-1,3-thiazol-5-yl}-N-phenylacetamide |
Molecular Weight: | 528.63 |
Molecular Formula: | C29 H28 N4 O4 S |
Smiles: | Cc1ccc(cc1)C1CC(c2ccc(c(c2)OC)OC)N(C2=NC(C(CC(Nc3ccccc3)=O)S2)=O)N=1 |
Stereo: | MIXTURE OF STEREOISOMERS |
logP: | 4.9054 |
logD: | 4.9054 |
logSw: | -4.704 |
Hydrogen bond acceptors count: | 9 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 74.233 |
InChI Key: | FIQXLMRBKZELMK-UHFFFAOYSA-N |